Knowledge base
MedicinesChecked against the official source
Pharmaceutical-sector development measures for 2022–2026 — UP-55
Sector decree containing provisions on GMP, GDP and GPP implementation and product conformity. These sections provide context for the dedicated quality procedures.
- Act type
- Presidential Decree
- No.
- UP-55
- Adopted
- 21 January 2022
- Section
- Quality, GxP and pharmacopoeia
Official text
Pharmaceutical-sector development measures for 2022–2026 — UP-55
Presidential Decree · No. UP-55 · 21 January 2022
Related documents
- Cabinet of Ministers Resolution · No. 472 · 7 September 2026Checked against the official sourceOn additional measures to improve legislation on technical regulationMedicines
- Order of the Minister of Health · No. 14 · 10 April 2026Checked against the official sourceProcedure for setting fees for GxP pharmaceutical inspection of pharmaceutical enterprises and preclinical and clinical research sitesMedicinesMedical devices and equipment
- Order of the Minister of Health · No. 13 · 16 December 2025Checked against the official sourceCertification-rule amendments covering GMP and ISO 13485 — No. 3386-2MedicinesMedical devices and equipment
- Order of the Minister of Health · No. 14 · 12 December 2025Checked against the official sourceDevelopment and inclusion of general and individual pharmacopoeial monographsMedicines